# Clinical use of cardiovascular magnetic resonance-defined synthetic extracellular volume fraction

**Authors:** David A. Bluemke, Prashant Nagpal

PMC · DOI: 10.1016/j.jocmr.2025.101891 · 2025-04-09

## Full-text entities

- **Genes:** LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}
- **Diseases:** acute myocardial infarction (MESH:D009203), edema (MESH:D004487), myocardial damage (MESH:D009202), amyloidosis (MESH:D000686), myocardial scar (MESH:D002921), amyloid protein deposition (MESH:D058225), myocardial disease (MESH:D004194), critically ill (MESH:D016638), infarction (MESH:D007238), fibrosis (MESH:D005355), iron overload (MESH:D019190), anemia (MESH:D000740), cardiovascular diseases (MESH:D002318), aortic stenosis (MESH:D001024), Anderson-Fabry disease (MESH:D000795), inflammation (MESH:D007249)
- **Chemicals:** gadolinium (MESH:D005682), iron (MESH:D007501), glycosphingolipids (MESH:D006028), ECV (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12182822